Literature DB >> 34251503

Anxiolytic-like effect of natural product 2-hydroxy-3,4,6-trimethoxyacetophenone isolated from Croton anisodontus in adult zebrafish via serotonergic neuromodulation involvement of the 5-HT system.

Antonio Wlisses da Silva1, Maria Kueirislene A Ferreira2, Emanuela L Rebouças1, Francisco Rogenio S Mendes3, Atilano Lucas Dos S Moura2, Jane Eire S A de Menezes2, Márcia Machado Marinho4, Emmanuel Silva Marinho4, Hélcio S Santos1,2,3,5, Alexandre M R Teixeira6,7.   

Abstract

Benzodiazepines are highly effective in combating anxiety; however, they have considerable adverse effects, so it is important to discover new safe anxiolytic agents. This study was designed to investigate the effect of the natural product 2-hydroxy-3,4,6-trimethoxyacetophenone (HTMCX) on anxiety and seizure behavior in adult zebrafish and its possible mechanisms of action. The acute toxicity of 96 h of HTMCX was analyzed, and the open and light/dark field tests (n = 6 animals/group) were used to assess the anxiety behavior of animals treated with HTMCX. In addition, the mechanisms of action were investigated with antagonists of the GABAA, 5-HT receptors, and molecular anchorage study. Pentylenetetrazole (PTZ) was used to induce seizure by immersion. As a result, acetophenone HTMCX (1, 3 and 10 mg/kg; v.o.) was non-toxic and affected locomotor activity. The higher doses (3 and 10 mg/kg; v.o.) produced signs of anxiolytic action in the light/dark test, and this effect was reversed by the pizotifen (antagonist 5HTR1 and 5HTR2A/2C), having the potential to form a complex with 5HTR1B. However, the anxiolytic effect of HTMCX has not been abolished by flumazenil (antagonist GABAA), cyproheptadine (antagonist 5HTR2A), and granisetron (antagonist 5HTR3A/3B). Therefore, HTMCX demonstrated an anxiolytic effect, suggesting that the 5HTR1 and 5HTR2C receptors may be involved in the pharmacological performance of this acetophenone in the central nervous system.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  5HTR1/2C; Anxiety; Croton; Zebrafish

Mesh:

Substances:

Year:  2021        PMID: 34251503     DOI: 10.1007/s00210-021-02116-z

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  33 in total

1.  Pharmacological insights on the antidepressant, anxiolytic and aphrodisiac potentials of Aglaonema hookerianum Schott.

Authors:  Osman Goni; Mohammad Forhad Khan; Md Masudur Rahman; Md Zahid Hasan; Faisal Bin Kader; Nasim Sazzad; Mahfuz Ahmed Sakib; Barbara Romano; Md Areeful Haque; Raffaele Capasso
Journal:  J Ethnopharmacol       Date:  2020-12-02       Impact factor: 4.360

2.  Effects of anxiolytics in zebrafish: similarities and differences between benzodiazepines, buspirone and ethanol.

Authors:  Daiane L Gebauer; Natália Pagnussat; Angelo L Piato; Isabel C Schaefer; Carla D Bonan; Diogo R Lara
Journal:  Pharmacol Biochem Behav       Date:  2011-05-05       Impact factor: 3.533

3.  Similar anxiolytic effects of agonists targeting serotonin 5-HT1A or cannabinoid CB receptors on zebrafish behavior in novel environments.

Authors:  Kristin A Connors; Theodore W Valenti; Kelly Lawless; James Sackerman; Emmanuel S Onaivi; Bryan W Brooks; Georgianna G Gould
Journal:  Aquat Toxicol       Date:  2013-12-12       Impact factor: 4.964

4.  Perceptions, clinical characteristics, and other factors associated with prolonged and high daily dose of benzodiazepine use among patients with anxiety or depressive disorders.

Authors:  Yu-Ting Chen; Chia-Yih Liu; Chia-Ming Chang; Yu-Ming Lai; Bi-Hwa Wang; Tsui-Yun Yang; Shih-Chieh Hsu
Journal:  J Affect Disord       Date:  2020-04-19       Impact factor: 4.839

5.  Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care.

Authors:  Borwin Bandelow; Leo Sher; Robertas Bunevicius; Eric Hollander; Siegfried Kasper; Joseph Zohar; Hans-Jürgen Möller
Journal:  Int J Psychiatry Clin Pract       Date:  2012-04-30       Impact factor: 1.812

6.  Maerua angolensis stem bark extract reverses anxiety and related behaviours in zebrafish-Involvement of GABAergic and 5-HT systems.

Authors:  Charles Kwaku Benneh; Robert Peter Biney; Priscilla Kolibea Mante; Augustine Tandoh; Donatus Wewura Adongo; Eric Woode
Journal:  J Ethnopharmacol       Date:  2017-06-20       Impact factor: 4.360

7.  Anxiolytic-like effect of chalcone N-{4'[(2E)-3-(3-nitrophenyl)-1-(phenyl)prop-2-en-1-one]} acetamide on adult zebrafish (Danio rerio): Involvement of the 5-HT system.

Authors:  Maria Kueirislene Amâncio Ferreira; Antonio Wlisses da Silva; Francisca Crislândia Oliveira Silva; Antônio Eufrásio Vieira Neto; Adriana Rolim Campos; Sacha Aubrey Alves Rodrigues Santos; Alexandre Magno Rodrigues Teixeira; Jayze da Cunha Xavier; Paulo Nogueira Bandeira; Carlos Emídio Sampaio Nogueira; Débora Hellen Almeida de Brito; Emanuela Lima Rebouças; Francisco Ernani Alves Magalhães; Jane Eire Silva Alencar de Menezes; Hélcio Silva Dos Santos
Journal:  Biochem Biophys Res Commun       Date:  2020-03-30       Impact factor: 3.575

Review 8.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

Review 9.  Cognitive behavioral therapy for anxiety and related disorders: A meta-analysis of randomized placebo-controlled trials.

Authors:  Joseph K Carpenter; Leigh A Andrews; Sara M Witcraft; Mark B Powers; Jasper A J Smits; Stefan G Hofmann
Journal:  Depress Anxiety       Date:  2018-02-16       Impact factor: 6.505

10.  Benzodiazepine pharmacology and central nervous system-mediated effects.

Authors:  Charles E Griffin; Adam M Kaye; Franklin Rivera Bueno; Alan D Kaye
Journal:  Ochsner J       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.